Current $15 is above DCF FV $13. P(above)=22.6% — model gives 77% odds of underperformance. Prior target $19.50 looks stale. Integration risk (post-Cadence), Category III regulatory transition, and macro headwinds are real. With stock above DCF FV and no near-term catalyst visible, lean avoid.
Fair Value Distribution — percentile bands
22.5% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
8.7%/yr
±4.6% · revenue growth to justify current price
FCF-Based Reverse DCF
2.5%/yr
±2.7% · FCF growth to justify current price
THE GAP
Market pricing margin expansion or capex normalization
KEY VALUE DRIVERS
Spearman correlation — what moves this valuation most
Eagle will generate this view by the next trading session (~6h).
Eagle will generate this view by the next trading session (~6h).
HBAN completed Cadence acquisition on Feb 1, 2026, becoming a B+ regional bank. While capital-strong and strategically positioned, company faces significant integration execution risk, Category III re...